Baker Bros. Advisors LP Adaptive Biotechnologies Corp Transaction History

Baker Bros. Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $14.1 Million - $25.7 Million	-379,682 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $2.74 Million - $3.98 Million	-60,857 Reduced 13.81%	379,682 $22.5 Million
Q3 2020 Nov 16, 2020	SELL	$35.79 - $48.81 $823,170 - $1.12 Million	-23,000 Reduced 4.96%	440,539 $21.4 Million
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $6.99 Million - $13.6 Million	-280,195 Reduced 37.67%	463,539 $22.4 Million
Q1 2020 May 15, 2020	SELL	$16.96 - $34.16 $6.3 Million - $12.7 Million	-371,677 Reduced 33.32%	743,734 $20.7 Million
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $1.23 Million - $1.64 Million	-50,000 Reduced 4.29%	1,115,411 $33.4 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $47 Million - $56.3 Million	1,165,411 New	1,165,411 $56.3 Million

187

152M

8.4K

56K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $714M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.